VERTEX PHARMACEUTICALS INC / MA Deferred Tax Assets, Unrealized Currency Losses
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Deferred Tax Assets, Unrealized Currency Losses of $0 as of 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses · last filed 2017-02-23
- 2016-12-31: Deferred Tax Assets, Unrealized Currency Losses $0.00.
- 2015-12-31: Deferred Tax Assets, Unrealized Currency Losses $222.00K.
- 2014-12-31: Deferred Tax Assets, Unrealized Currency Losses $0.00.
- 2013-12-31: Deferred Tax Assets, Unrealized Currency Losses $217.00K.
| Period end | Deferred Tax Assets, Unrealized Currency Losses |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-23 |
| 2015-12-31 | $222.00K 10-K · filed 2017-02-23 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-16 |
| 2013-12-31 | $217.00K 10-K · filed 2015-02-13 |
| 2012-12-31 | $0.00 10-K · filed 2014-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |